JPM'L JPMorgan Chase & Co Preferred Stock
NOW TRADING POST CALL DATEJPM'L is JPMorgan Chase & Co's 4.625% non-cumulative Series LL preferred stock with a $25.00 liquidation preference. At $16.46 (Nov 17, 2026 close) it trades 34.2% ($8.54) below par for a 7.02% current yield. It has been callable at par since Jun 1, 2026. Its terms are verified against the SEC prospectus linked on this page.
About this security
JPM'L is a 4.625% non-cumulative perpetual preferred stock issued by JPMorgan Chase & Co, grouped under Banking & Savings. $25 liquidation preference, current yield 7.02%, callable from 2026-06-01.
JPMorgan Chase & Co: JPMorgan Chase & Co. (NYSE: JPM) is a U.S.-based financial holding company and one of the world's largest financial institutions, with $4.4 trillion in assets and $362.4 billion in stockholders' equity as of December 31, 2025. The Firm operates across investment banking, consumer and small business financial services, commercial banking, financial transaction processing, and asset management under the J.P. Morgan and Chase brands. Its principal banking subsidiary, JPMorgan Chase Bank, N.A., maintains branches in 48 states and Washington, D.C., while its international operations span overseas branches, subsidiaries, and representative offices, with major non-U.S. subsidiaries based in the U.K. and Germany. Company website
Key Stats ✓ Verified against SEC filing
vs. Banking & Savings (95 issues with a current yield): yield 7.02% vs avg 7.43% · discount -34.2% vs avg -19.9%
Quote
| JPM'L (preferred) | JPM (common) | |
|---|---|---|
| As of | 2026-11-17 | 2026-11-16 |
| Last | $16.46 | $338.21 |
| Change | +0.08 (+0.49%) | -7.98 (-2.31%) |
| Open | $16.44 | $345.57 |
| High / Low | $16.52 / $16.32 | $346.52 / $336.67 |
| Prev Close | $16.38 | $346.19 |
| Volume | 660,666 | 7,250,318 |
| 52-Week High / Low | $20.30 / $16.32 | $366.50 / $279.10 |
Charts & data for JPM on Finviz ↗ Sponsored
End-of-day closes, dated in the first row. A quote 3 or more trading sessions old is flagged stale, and a stale common quote is withheld. Change and Prev Close compare with the previous session's close. 52-week range based on available history, adjusted for splits. Shares outstanding / market cap require a fundamentals feed (not in current data plan).
Price
Dividend History
| Ex-Date | Amount / Share |
|---|---|
| 2026-11-02 | $0.289075 |
| 2026-08-03 | $0.289075 |
| 2026-05-04 | $0.289075 |
| 2026-01-30 | $0.289075 |
| 2025-11-03 | $0.289075 |
| 2025-08-04 | $0.289075 |
| 2025-05-02 | $0.289075 |
| 2025-01-30 | $0.289075 |
| 2024-11-01 | $0.289075 |
| 2024-08-02 | $0.289075 |
| 2024-05-01 | $0.289075 |
| 2024-01-30 | $0.289075 |
Performance: $10K Calculator
Dividends reinvested (DRIP) at the close on each ex-date. Full performance page →
Other Securities from JPMorgan Chase & Co
Of JPMorgan Chase & Co's 5 listed preferreds and baby bonds, JPM'M trades at the widest discount to par: 38.9% ($9.73) below its $25.00 par. JPM'M also has the highest yield to worst, 11.98%.
| Symbol | Type | Coupon | Price | Par | Prem/Disc | Call Date | Yield to Worst | Cumulative | ReinvestCapture™ Rate | Yield |
|---|---|---|---|---|---|---|---|---|---|---|
| JPM'D | preferred | 5.750% | 20.76 | $25.00 | -16.96% (−$4.24) | 2023-12-01 post-call | 6.92% | No | 8.34% | 6.92% |
| JPM'J | preferred | 4.750% | 16.92 | $25.00 | -32.32% (−$8.08) | 2024-12-01 post-call | 7.02% | No | 10.37% | 7.02% |
| JPM'K | preferred | 4.550% | 16.17 | $25.00 | -35.32% (−$8.83) | 2026-06-01 post-call | 7.03% | No | 10.88% | 7.03% |
| JPM'M | baby bond | 3.800% | 15.27 | $25.00 | -38.92% (−$9.73) | 2014-09-30 post-call | 11.98% | n/a | 11.26% | 6.88% |
News: JPMorgan Chase & Co
- JPMorgan Taps de Best to Succeed CFO Jeremy Barnum · finance.yahoo.com · Nov 17, 2026
- JPMorgan Still Sees Moderna Overvalued Despite Raising Its Target · finance.yahoo.com · Nov 17, 2026
- JPMorgan and MIT Map More Than 150 Requirements for Institutional Blockchains · newsbtc.com · Nov 17, 2026
- JPMorgan Chase & Co. Boosts Voting Stake in Paladin Energy to 10.15% from 6.52% · kalkinemedia.com · Nov 17, 2026
- JPMorgan Chase & Co. Boosts Stake in Clinuvel Pharmaceuticals to 7.96% as of November 2026 - Kalkine Media · kalkinemedia.com · Nov 17, 2026
- JPMorgan Chase (JPM) Launches After Hours Token Transfers And Backs $500 Million Financing · finance.yahoo.com · Nov 17, 2026
Issuer news via Tiingo, filtered to stories about JPM.